Sunovion's Seizure Drug Aptiom Wins Monotherapy Use
Marlborough, Massachusetts-based Sunovion Pharmaceuticals won the FDA's approval to market Aptiom (eslicarbazepine acetate) as monotherapy to treat partial-onset seizures.
Marlborough, Massachusetts-based Sunovion Pharmaceuticals won the FDA's approval to market Aptiom (eslicarbazepine acetate) as monotherapy to treat partial-onset seizures.